-
hcup-us.ahrq.gov/db/nation/nass/stats/NASS_Summary_Stats_DX_PR_GRPS_Weighted_2022.pdf
January 01, 2022 - Deformations and Chromosomal Abnormalities 9097088 0 0 1.000000 0.023405 0.001094 289769 14869
DXCCSR_SYMnnn Symptoms … Respiratory System 490,781 3.96%
SKNnnn: Diseases of the Skin and Subcutaneous Tissue 79,197 0.64%
SYMnnn: Symptoms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2019.pdf
January 01, 2019 - Malformations, Deformations and Chromosomal Abnormalities 8,994,101 0 0 1 0.0 220,546
DXCCSR_SYMnnn : Symptoms … 98.36%
SKNnnn: Diseases of the Skin and Subcutaneous Tissue 64,091 0.71% 8,910,787 99.07%
SYMnnn: Symptoms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2020.pdf
January 01, 2020 - Chromosomal Abnormalities
7,828,310 0 0 1 252,770 12,626.98 228,010.51 277,528.50
19 DXCCSR_SYMnnn Symptoms … 98.49%
SKNnnn: Diseases of the Skin and Subcutaneous Tissue 70,391 0.68% 10,251,993 99.17%
SYMnnn: Symptoms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2019.pdf
January 01, 2019 - Chromosomal Abnormalities
8,994,101 0 0 1 285,375 14,132.43 257,664.11 313,085.39
19 DXCCSR_SYMnnn Symptoms … 98.35%
SKNnnn: Diseases of the Skin and Subcutaneous Tissue 84,615 0.71% 11,768,570 99.06%
SYMnnn: Symptoms
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2020.pdf
January 01, 2020 - Malformations, Deformations and Chromosomal Abnormalities 7,828,310 0 0 1 0.0 195,433
DXCCSR_SYMnnn : Symptoms … 98.48%
SKNnnn: Diseases of the Skin and Subcutaneous Tissue 53,606 0.68% 7,762,974 99.17%
SYMnnn: Symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/genetic-testing-developmental-disabilities_research-protocol.pdf
September 30, 2014 - Some DDs (e.g., cerebral palsy, hearing loss, vision impairment) can be diagnosed based
upon clinical symptoms … Health outcomes: are symptoms and conditions that patients can feel or experience, such
as visual impairment
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - ASCVD as
a grouped value set that includes diagnosis and procedure concepts reflecting signs and
symptoms
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
October 01, 2017 - defined by a grouped value set that includes diagnosis and procedure concepts that reflect signs and symptoms
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - representing CVD as a grouped value set
that includes diagnosis and procedure concepts to reflect signs and symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-evidence-summary.pdf
April 01, 2019 - Insufficient
Clinical Outcomes (KQ1):
Psychiatry
3 (in five
articles)
Decrease in symptoms and high
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
October 04, 2016 - Juvenile Justice Girls Depressive Symptoms and Suicidal
Ideation 9 Years After Multidimensional Treatment
-
www.ahrq.gov/patient-safety/reports/hotline/design2.html
May 01, 2016 - ambiguous (e.g., degree or nature of harm, patients’ or caregivers’ attribution of causes, persistence of symptoms
-
www.ahrq.gov/sites/default/files/2024-01/lord-report.pdf
January 01, 2024 - ’s condition meets one or more criteria (trigger) from a pre-determined set of physical signs and
symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/047-evidence-behind-decolonization-strategies-notes.docx
October 01, 2024 - Colonization is defined as the presence of bacteria on or in a patient’s body without any current signs or symptoms
-
www.ahrq.gov/sites/default/files/2025-03/wears-perry-report.pdf
January 01, 2025 - In this case, the wrong
symptoms are entered into the electronic white board and, as a result, the
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_5-mutual-support-speaker-notes.pdf
July 01, 2023 - standard response to maternal early‐warning signs, including listening to and investigating
patient symptoms
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_5-mutual-support.pptx
July 01, 2023 - standard response to maternal early-warning signs, including listening to and investigating patient symptoms
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs025654-lenert_final-report-2023.pdf.pdf
January 01, 2023 - : MUSC developed and deployed an institution-wide protocol for screening patients for IPV
signs or symptoms
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4z_ByGyYfKV5uRU6fjx8pB
March 01, 2014 - about the effectiveness of specific pre-
ventive care services for patients without related signs or
symptoms
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4zmYnqJXLv8g4LzLrrDDrm
December 01, 2014 - about the effectiveness of specific preven-
tive care services for patients without related signs or
symptoms